Controversies surrounding authorship of manuscripts by industry employees: academic and industry perspectives
- 1 March 2018
- journal article
- review article
- Published by Europa Digital & Publishing in EuroIntervention
- Vol. 13 (16), 1967-1974
- https://doi.org/10.4244/eij-d-16-00918
Abstract
The medical device and pharmaceutical industries play an essential role in the development of cardiovascular devices and drugs, and industry employees are frequently listed as co-authors of clinical trials published in peer-reviewed journals. Potential conflicts of interest in biomedical research have attracted significant attention in recent years, but issues and challenges surrounding authors who are industry employees have not received nearly as much scrutiny. We present a comprehensive discussion of the concerns and challenges regarding the role of industry in the authorship of scientific manuscripts. Academic co-authors, industry employees, the editors of medical journals, and, most importantly, readers, need to consider the perception and implications that accompany industry employee authorship. Potential concerns include the effect of industry authors (and industry support) on study design, data analysis, interpretations, conclusions, and, ultimately, scientific content. Meaningful contributions from industry employees must be acknowledged and reported in scientific and clinical publications. Efforts to provide full transparency on industry support and the role of industry contributors are necessary to maintain confidence in the reports of studies with industry involvement.Keywords
This publication has 25 references indexed in Scilit:
- Authors' Self-Declared Financial Conflicts of Interest Do Not Impact the Results of Major Cardiovascular TrialsJournal of the American College of Cardiology, 2013
- A Randomized Study of How Physicians Interpret Research Funding DisclosuresThe New England Journal of Medicine, 2012
- Conflicts of Interest in Cardiovascular Clinical Practice GuidelinesArchives of Internal Medicine, 2011
- Good publication practice for communicating company sponsored medical research: the GPP2 guidelinesBMJ, 2009
- Requirements and Definitions in Conflict of Interest Policies of Medical JournalsJAMA, 2009
- The continuing dilemma of competing interestsArchives of Disease in Childhood, 2008
- Consistency of Financial Interest Disclosures in the Biomedical Literature: The Case of Coronary StentsPLOS ONE, 2008
- Ghost Authorship in Industry-Initiated Randomised TrialsPLoS Medicine, 2007
- Authorship Criteria and Disclosure of ContributionsJAMA, 2004
- Relationships between Academic Institutions and Industry in the Life Sciences — An Industry SurveyThe New England Journal of Medicine, 1996